Penn Medicine Provider
Hematology, Medical Oncology
Kristine Marie Ward, MD
5.0
(301)
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Radnor
View 1 additional location
Make an appointmentCall 800-789-7366

About me

  • Clinical Assistant Professor of Medicine (Hematology-Oncology)

Education and training

  • Medical School: Jefferson Medical College
  • Residency: Lankenau Hospital
  • Residency: Pennsylvania Hospital
  • Fellowship: Drexel University

What my patients think about me

Average Rating
5.0

301 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

April 2025
5.0
5.0
dr. ward will do all she can professionally to make sure the patient is taken of.
April 2025
5.0
5.0
she is excellent
March 2025
5.0
5.0
my doctor is thorough, professional, always listens and answers all my questions completely.
March 2025
5.0
5.0
dr. ward is amazing and very thorough

Insurance accepted

My Locations

Learn about location
Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. Ward is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Hugo Lara- Martinez, Kristine Ward Michael Styler, Praneeth Baratam Angiosarcoma of the Face: A Case Study and Literature Review of Local and Metastatic Angiosarcoma , Case Reports in Oncological Medicine , 2021: 2021

S Bukhari Kristine Ward Michael Styler Hepatocellular Carcinoma First Manifestation as Solitary Humeral Bone Metastasis , Case Reports in Oncological Medicine : 2020

Ronak Mistry Kristine Ward Sickle Induced Cholestasis: A Rare but Fatal Complication of Sickle Cell Disease , PA ACP Southeastern Chapter Abstract # 31: 2020

Wilbur Bowne, Michael J Styler Kristine Ward targeting membrane HDM 2 by PNC 27 Induces Necrosis in leukemia Cells but not in normal Hematopoietic Cells , Anticancer Research , 40(9): 2020,4857-4867

Kyung D, Perimbeti S, Adepoju B, Hanson S, McCormack M, Ward K, Jain M, Styler M Relationship between underlying causes of HCC and its complications , J Clin Oncol: 2019

Bemis T, Baratam P, Seiders D, Ward K, Styler M Impact of timing of palliative care team consults in patients with advanced cancer , J Clin Oncol: 2019

Perimbeti S, Shrivastav R, Stanchina M, Pathak P, Rainone M, Jain M, Ward K, Styler M Trends in mortality due to hypercalcemia in breast cancer. , J Clin Oncol: 2019

Perimbeti S, Shrivastav R, Jatwani K, Ward K, Styler M, Jain M, Nandi N Impact of Clostridium difficile infection on gastrointestinal malignancies , J Clin Oncol: 2019

Gleeson EM, Feldman R, Mapow BL, Mackovick LT, Ward KM, Morano WF, Rubin RR, Bowne WB. Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy. , Am J Clin Oncol., 41(8): 2018,777-783

Schmalz L, Trisel Z, Perimbeti S, Lee W, Topolsky D, Crilley P, Ward K, Styler M Malignant pleural effusions: Do race, obesity and comorbidities play a role? , J Clin Oncol: 2018